It is well known that polypharmacy has the potential to result in adverse events for patients. Therefore, the prescribing process must not only include a review, but also the cessation of medicines. This Course looks at polypharmacy and deprescribing.
- Correlate the challenges of an ageing population with medication use and polypharmacy
- Explain to the patient or their carer the rationale for deprescribing medicines as indicated
- Critically evaluate medicines that are at higher risk of causing older adults to experience medication-related problems
- Plan and initiate a withdrawal trial taking into account medicines that should be ceased slowly
No conflict of interest exists for anyone in the position to control content for this activity. Wherever possible, generic or non-proprietary names of medications or products have been used.
Jenny Gowan, a practising pharmacist, is a teaching associate at Monash University, Melbourne and a clinical associate of RMIT University. She is a member of the PSA Branch committee, the Expert Group for Therapeutic Guidelines – Respiratory version 5, an editorial board member of AUS-DI, SHPA "Don’t Rush to Crush", the Guidelines Committee for the Australian Asthma Handbook (AAH) and the writing group for the RACGP ‘Medical Care of older persons in RACF’ (Silver book). Jenny is an accredited consultant pharmacist who conducts her own company, which focuses on medication reviews in the home and aged care facilities, plus education, writing, training, and consultation. Jenny works regularly in community pharmacy plus sessions in a GP clinic at a Community Health Centre. She has published over 400 educational articles. Jenny has presented talks at many Australian and international conferences to GPs, nurse practitioners, nurses, podiatrists, pharmacists, and other health professionals. In 2013, she was awarded the Australian Pharmacist of the Year by the Pharmaceutical Society of Australia and, in 2016, the AACP-MIMs Australian Consultant Pharmacist of the Year.